Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation

v3.25.0.1
Stock-based Compensation
 3 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Stock-based Compensation
Note 11. Stock-based Compensation
Effective January 27, 2015, the Company’s Board of Directors adopted the 2015 Stock Incentive Plan (the “2015 Plan”) which provides for up to 1,250,000 common shares available for issuance to provide a long-term incentive plan for officers, employees, directors and/or consultants to directly link incentives to stockholder value. The 2015 Plan was approved by the Company’s stockholders in February 2015. The Company’s 2015 Plan provides for grants to eligible participants in various forms including restricted shares of the Company’s common stock and stock options. Awards are discretionary and are determined by the Compensation Committee of the Board of Directors. Awards vest based upon service conditions. Non-vested restricted shares generally vest over requisite service periods of one to six years from the date of grant.
The Company recognizes stock-based compensation expense for (i) Board of Directors fees (generally paid in treasury stock), and (ii) other awards under the 2015 Plan (paid in restricted stock, stock options or Market-based Restricted Stock Units (“MRSUs”)). Stock-based compensation expense is recognized in general and administrative expenses in the Condensed Consolidated Statements of Operations.
Stock Compensation – Board of Directors
The Board of Directors can either elect to receive stock compensation or cash for their fees for services provided. Stock-based compensation expense relating to the Board of Directors fees was $119 for the three months ended December 31, 2024, and $138 for the three months ended December 31, 2023.
Stock Compensation - Employees
Stock compensation expense related employee awards was $60 for the three months ended December 31, 2024, and December 31, 2023.
Restricted Stock Awards (“RSAs”)
Restricted Stock Awards Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 17,500 $ 37.82 
Outstanding at December 31, 2024 (a) 17,500 $ 37.82 
a.The weighted average remaining contractual term is 0.5 years and the aggregate intrinsic value of RSAs expected to vest is $454.
There was $94 and $150 of total unrecognized stock compensation costs related to unvested stock compensation for the RSAs at December 31, 2024 and September 30, 2024, respectively.
Stock Option Grants
Number of
Options		 Weighted
Average
Exercise
Price		 Weighted
Average
Remaining
Contractual
Term
(years)		 Aggregate
Intrinsic
Value
Vested and outstanding - December 31, 2024 38,000 $ 33.75  2.0 —
At December 31, 2024 and September 30, 2024, there was no unrecognized stock compensation cost related to unvested share-based compensation for the option grants.
Market-based Restricted Stock Units
On December 23, 2024, the Company granted MRSUs to one of its executives, which will be eligible to be earned if at any time prior to September 30 2027, the average 30-day closing per share price of the Company’s Common Stock exceeds the applicable price per share thresholds set forth in below:

Price Per Share Threshold
Number of MRSUs Earned
$35 per share
 5,000
$40 per share
 12,500
$45 per share
 20,500

The earned MRSUs will then be subject to time-based vesting on September 30, 2027, subject to continued service through such date, Stock compensation expense will be recognized ratably over the term of the award.

The assumptions used in the Monte Carlo simulation model to calculate the fair value of the Company’s MRSUs are as follows:

Three months ended
December 31, 2024
Expected volatility of stock price 33.14  %
Risk-free interest rate 4.26  %
Expected term of awards (years) 2.77
Dividend yield 0.76  %
Grant date stock price $ 26.15 
Market-based Restricted Stock Units Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 —  $ — 
Granted 38,000 $ 12.32 
Vested —  $ — 
Forfeited —  $ — 
Outstanding at December 31, 2024 (a) 38,000 $ 12.32 
a.The weighted average remaining contractual term is 2.8 years and the aggregate intrinsic value of MRSUs expected to vest is $985.
As of December 31, 2024 and September 30, 2024, total unrecognized stock compensation costs for MRSUs was $464 and $0, respectively.
Forfeitures of RSAs, stock options and MRSUs are recognized as incurred.
Total stock-based compensation expense, which was recognized in general and administrative expense, was $179 and $194 for the three months ended December 31, 2024 and 2023, respectively.